| Literature DB >> 24358884 |
Claudia Colasante1, Frank Voncken2, Theresa Manful3, Thomas Ruppert4, Aloysius G M Tielens5,6, Jaap J van Hellemond5, Christine Clayton4.
Abstract
In kinetoplastid protists, several metabolic pathways, including glycolysis and purine salvage, are located in glycosomes, which are microbodies that are evolutionarily related to peroxisomes. With the exception of some potential transporters for fatty acids, and one member of the mitochondrial carrier protein family, proteins that transport metabolites across the glycosomal membrane have yet to be identified. We show here that the phosphatidylcholine species composition of Trypanosoma brucei glycosomal membranes resembles that of other cellular membranes, which means that glycosomal membranes are expected to be impermeable to small hydrophilic molecules unless transport is facilitated by specialized membrane proteins. Further, we identified 464 proteins in a glycosomal membrane preparation from Leishmania tarentolae. The proteins included approximately 40 glycosomal matrix proteins, and homologues of peroxisomal membrane proteins - PEX11, GIM5A and GIM5B; PXMP4, PEX2 and PEX16 - as well as the transporters GAT1 and GAT3. There were 27 other proteins that could not be unambiguously assigned to other compartments, and that had predicted trans-membrane domains. However, no clear candidates for transport of the major substrates and intermediates of energy metabolism were found. We suggest that, instead, these metabolites are transported via pores formed by the known glycosomal membrane proteins.Entities:
Year: 2013 PMID: 24358884 PMCID: PMC3814921 DOI: 10.12688/f1000research.2-27.v1
Source DB: PubMed Journal: F1000Res ISSN: 2046-1402
Figure 1. Purification of glycosomal membrane-enriched fractions from L. tarentolae.
A. Western blot analysis of the different L. tarentolae fractions obtained after density gradient centrifugation. Equal volumes of only the odd-numbered fractions were loaded for analysis. Antibodies used for detection are indicated next to the western blot panels. Mitochondrial [19– 29] and glycosomal [9– 19] density gradient fractions are indicated. B. SDS-PAGE gel stained with Coomassie brilliant blue, showing protein bands from intact glycosomes (glycosomal fraction, and from the glycosomal membrane-enriched pellet (urea pellet). Arrows indicate enriched proteins in the urea-treated glycosomal membrane fraction.
Supplementary Figure S1. Immunofluorescence analysis of the putative glycosomal membrane proteins in procyclic T. brucei.
N-terminally or C-terminally myc-tagged versions of the proteins were detected (green) by using a commercial Myc antibody (Sigma-Aldrich). Mitochondria were visualized (red) using mitotracker. The endoplasmatic reticulum (ER) was detected using an antibody directed against the ER lumen protein BiP (red). Overlays (Merge) of the green staining and the red staining are shown to visualize the common compartmentalization of the proteins. On the right side, western blots are shown to illustrate the expression of the myc-tagged membrane proteins. (+) and (-) indicate tetracycline-induced and -uninduced cells respectively.
Figure 2. Putative glycosomal pathway scheme.
The scheme summarizes metabolic pathways identified so far in the glycosomes of Leishmania and T. brucei. EC numbers of enzymes identified only in the Leishmania glycosome are indicated in black boxes with white text, those identified only in T. brucei are indicated in italics, and those found in the glycosome of both species are indicated in bold. Predicted transport processes across the glycosomal membrane are indicated by the circled question marks and dashed arrows. Letters in black circles indicate the different metabolic pathways as follows: A: glycolysis; B: succinic fermentation; C: pentose phosphate pathway; D: superoxide and trypanothione metabolism; E: purine salvage; F: pyrimidine metabolism; G: mannose metabolism; H: glycerolipid biosynthesis; I: β-oxidation of fatty acids; L: phosphoarginine metabolism; M: mevalonate pathway; N: phospholipid degradation. Abbreviations used are: Acyl-GPC, 1-acyl-glycero-phosphocholine; Acyl-GPE, 1-acyl-glycero-phosphoethanolamine; AOX, alternative oxidase; DHA, dehydroascorbate; MDHA, monodehydroxyascorbate; NB, nucleobases; PRPP, 5-phosphoribosyl 1-pyrophosphate.
Known proteins of the glycosomal membrane.
This list includes all mass-spectrometry-detected glycosomal membrane proteins.
| Lta gene ID | Peptides | Coverage | Tb gene ID | Function |
|---|---|---|---|---|
|
| 16 | 59% |
| PEX11 |
|
| 7 | 25% | ||
|
| 3 | 14% | ||
|
| 3 | 8% |
| PEX2 |
|
| 6 | 13% |
| PEX16 |
|
| 3 | 15% |
| |
|
| 2 | 13% |
| PMP4 |
|
| 12 | 48% |
| GIM5A,B |
|
| 5 | 5% |
| GAT2 |
|
| 4 | 6% |
| GAT3 |
Abbreviations used: Lta, Leishmania tarentolae; Tb, Trypanosoma brucei.
Possible additional glycosomal membrane proteins.
This list includes all detected proteins with predicted trans-membrane (TM) domains, for which there is no evidence for location in any particular compartment.
| Lta gene ID | Pep nr | Cov (%) | Tb gene ID | Function | TMs (a) | TMs (b) | ER sp |
|---|---|---|---|---|---|---|---|
|
| 3 | 3 |
| Major facilitator family, nitrate and chloride transporter? | 12 | nd | no |
|
| 4 | 17 |
| putative tricarboxylate carrier, matches yeast putative alpha-isopropylmalate carrier, which exports alpha-isopropylmalate from the mitochondrion to the cytoplasm for use in leucine biosynthesis | 5 | nd | no |
|
| 2 | 6 |
| putative tricarboxylate carrier, matches yeast putative alpha-isopropylmalate carrier, which exports alpha-isopropylmalate from the mitochondrion to the cytoplasm for use in leucine biosynthesis | 5 | nd | no |
|
| 3 | 6 |
| hypothetical protein, conserved | 0 | 2 | no |
|
| 4 | 4 |
| hypothetical protein, conserved | 0 | 2 | no |
|
| 2 | 21 |
| hypothetical protein, conserved | 1 | 1 | no |
|
| 4 | 4 |
| P-loop nucleoside triphosphate hydrolase, contains EF hand domains | 0 | 1 | no |
|
| 4 | 6 |
| NTF2-like domain | 0 | 1 | no |
|
| 2 | 5 |
| ARM repeat superfamily | 0 | 1 | no |
|
| 2 | 3 |
| TERD-like domains | 0 | 1 | yes |
|
| 2 | 4 |
| hypothetical protein, conserved | 0 | 1 | no |
|
| 2 | 5 |
| hypothetical protein, conserved | 0 | 1 | no |
|
| 3 | 11 |
| hypothetical protein, conserved | 1 | nd | yes |
|
| 3 | 12 |
| hypothetical protein, DUF2012, peptidase superfamily, starch binding domain, similarity to human C15ORF24 | 1 | nd | yes |
|
| 2 | 8 |
| hypothetical protein, conserved | 1 | nd | no |
|
| 2 | 36 |
| hypothetical protein, conserved | 1 | nd | no |
|
| 3 | 10 |
| hypothetical protein, conserved | 1 | nd | no |
Abbreviations used: Lta, Leishmania tarentolae; Tb, Trypanosoma brucei; Pep nr, number of identified peptides; Cov (%), percentage of protein coverage; TMs (a), number of annotated trans-membrane domains; TMs (b), number of transmembrane-domains identified by THMM TOP; ER sp, endoplasmic reticulum signal peptide.
Phosphatidylcholine composition of procyclic-form and bloodstream-form T. brucei total cells and glycosomes.
| PCF | BSF | |||||
|---|---|---|---|---|---|---|
| Peak | Component | Glycosomes | Total cells | Glycosomes | Total cells | |
| Mol % | Mol % | Mol % | Mol % | |||
| 1 | PtdCho | 16:0, 16:1 | 2,9 | 1,7 ± 0,0 | 0,5 | 0,2 ± 0,2 |
| 2 | AlkCho | 16:0, 18:2 | 2,3 | 2,1 ± 0,3 | 0,7 | nd |
| 3 | PtdCho | 16:0, 18:3 | 3,3 | 1,7 ± 0,3 | 0,5 | nd |
| 4 | PtdCho | 16:0, 18:2 |
| 3,9 ± 0,5 | 2,5 | 3,9 ± 0,6 |
| 5 | PtdCho | 16:0, 18:1 | 2,8 | 3,1 ± 0,9 | 3,2 | 1,2 ± 0,3 |
| 6 | AlkCho | 16:0, 20:3 | 1,0 | 0,6 ± 0,0 | 0,2 | nd |
| 7 | EnylCho | 18:0, 18:2 | 0,9 | 1,0 ± 0,2 | 1,4 | 1,0 ± 0,2 |
| 8 | AlkCho | 18:0, 18:2 |
|
|
|
|
| 9 | PtdCho | 18:2, 18:2, 18:1, 18:3 |
|
|
| 4,4 ± 0,4 |
| 10 | PtdCho | 18:1, 18:2 |
|
| 4,3 |
|
| 11 | PtdCho | 18:0, 18:2, 18:1, 18:1 |
|
|
|
|
| 12 | PtdCho | 18:0, 18:1 | 2,4 | 1,2 ± 0,2 | 2,4 | 2,2 ± 0,4 |
| 13 | AlkCho | 16:0, 22:1, 18:0, 20:1 | 0,5 | 0,6 ± 0,1 | 3,5 | 0,4 ± 0,7 |
| 14 | PtdCho | 16:0, 22:6 | 1,4 | 0,9 ± 0,1 | nd | nd |
| 15 | PtdCho | 18:1, 20:5 | 2,8 | 3,9 ± 0,3 | 2,3 | 3,7 ± 0,3 |
| 16 | PtdCho | 16:0, 22:5 | 1,1 | 0,8 ± 0,0 | 1,1 | 2,1 ± 0,6 |
| 17 | PtdCho | 18:1, 20:4 | 1,3 | 2,6 ± 0,1 | nd | nd |
| 18 | PtdCho | 16:0, 22:4 | 0,9 | 0,8 ± 0,2 | 2,3 | 2,2 ± 0,6 |
| 19 | PtdCho | 18:0, 20:3 | 2,2 | 1,8 ± 0,7 | 3,0 | 4,1 ± 0,4 |
| 20 | PtdCho | 18:3, 22:5 | 4,0 |
| 4,9 | 4,5 ± 0,2 |
| 21 | PtdCho | 18:2, 22:5 | 0,3 | nd | 2,4 | 1,7 ± 0,3 |
| 22 | PtdCho | 18:1, 22:6 | 3,3 |
| 3,5 | 3,5 ± 0,7 |
| 23 | PtdCho | 18:3, 22:3 | 0,4 | 0,9 ± 0,3 | 3,0 | 2,6 ± 1,0 |
| 24 | PtdCho | 18:0, 22:6 | 2,4 | 3,2 ± 0,3 | 3,2 |
|
| 25 | PtdCho | 18:0, 22:5 | 2,6 |
| 3,7 | 3,6 ± 0,3 |
| 26 | PtdCho | 18:2, 22:3 | 0,0 | nd | 3,2 | 3,4 ± 0,3 |
| 27 | PtdCho | 18:0, 22:4 | 0,3 | 0,5 ± 0,1 |
| 3,7 ± 0,4 |
| 28 | PtdCho | 18:0, 22:3 | 0,2 | 0,2 ± 0,1 | 0,9 | 1,3 ± 0,5 |
| 29 | PtdCho | 20:4, 22:6 | 0,0 | 1,2 ± 0,0 | nd | nd |
| 30 | PtdCho | 20:4, 22:5 | 0,0 | 1,0 ± 0,1 | nd | nd |
The phosphatidylcholine species description comprises the sn-1 linkage type followed by the radyl chains on the sn-1 and sn-2 position, respectively. "Total cell" values are mean of three independent experiments. Most abundant species representing over 5 Mol % are marked in bold. Abbreviations: AlkCho, 1-alkyl, 2-acyl phosphatidylcholine; BSF, bloodstream-form T. brucei; EnylCho, 1-alkyl-1-enyl-2-acyl phosphatidylcholine; nd, not detected; PCF, procyclic-form T. brucei; PtdCho, diacyl phosphatidylcholine.